CVS HEALTH Corp Insider Trading Activity
Every SEC Form 4 insider transaction reported for CVS HEALTH Corp (CVS), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are CVS insiders buying or selling?
CVS HEALTH Corp insiders reported 20 open-market buys ($8.5M) and 62 sells ($820.7M) across 82 Form 4 filings — a net selling position of $812.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of May 21, 2026)
Insider sentiment
Net sellingNet insider flow of $812.3M in net selling.
Recent CVS insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 21, 2026 | Larry Robbins | Director | Sale | 3.4M | $94.15 | $317.5M |
| May 11, 2026 | Tilak Mandadi | EVP, Chief Exp & Tech Officer | Sale | 69.6K | $89.58 | $6.2M |
| Jan 27, 2026 | Steven H Nelson | EVP and President, Aetna | Purchase | 24 | $53.70 | $1.3K |
| Oct 14, 2025 | Heidi B Capozzi | EVP and Chief People Officer | Purchase | 80 | $57.36 | $4.6K |
| Aug 29, 2025 | Anne A. Finucane | Director | Sale | 7.5K | $71.02 | $532.6K |
| Jun 9, 2025 | Guy P Sansone | Director | Purchase | 1.6K | $63.70 | $100.0K |
| May 6, 2025 | Larry Robbins | Director | Sale | 3.8M | $67.65 | $253.7M |
| Mar 7, 2025 | James David Clark | SVP, Cont & Chief Acct Officer | Sale | 7.5K | $66.35 | $498.5K |
| Feb 19, 2025 | Michael F Mahoney | Director | Purchase | 30.0K | $66.70 | $2.0M |
| May 2, 2024 | Edward J Ludwig | Director | Purchase | 1.0K | $53.88 | $53.9K |
| May 2, 2024 | Michael F Mahoney | Director | Purchase | 9.2K | $54.49 | $500.3K |
| Feb 16, 2024 | Prem S Shah | EVP and Pres-Pharm, Consumer W | Sale | 29.5K | $76.95 | $2.3M |
| Nov 6, 2023 | Edward J Ludwig | Director | Purchase | 2.0K | $70.47 | $140.9K |
| May 5, 2023 | Karen S Lynch | President and CEO | Purchase | 14.0K | $69.75 | $976.6K |
| Dec 16, 2022 | Thomas M Moriarty | EVP & General Counsel | Sale | 137.5K | $98.36 | $13.5M |
| Aug 5, 2022 | Alan Lotvin | EVP&President-PharmacyServices | Sale | 143.4K | $98.94 | $14.2M |
| Aug 5, 2022 | Daniel P Finke | EVP/Pres, Health Care Benefits | Sale | 9.5K | $100.00 | $954.6K |
| Jun 30, 2022 | Thomas M Moriarty | EVP & General Counsel | Sale | 138.7K | $95.00 | $13.2M |
| Apr 12, 2022 | Prem S Shah | EVP and Co-President of Retail | Sale | 17.0K | $105.00 | $1.8M |
| Apr 6, 2022 | Daniel P Finke | EVP/Pres, Health Care Benefits | Sale | 61.3K | $100.12 | $6.1M |
| Mar 31, 2022 | Prem S Shah | EVP and Co-President of Retail | Sale | 5.3K | $104.70 | $559.7K |
| Mar 18, 2022 | Prem S Shah | EVP and Co-President of Retail | Sale | 4.6K | $106.65 | $493.1K |
| Mar 17, 2022 | Thomas M Moriarty | EVP & General Counsel | Sale | 51.4K | $105.00 | $5.4M |
| Feb 11, 2022 | Edward J Ludwig | Director | Purchase | 1.0K | $105.90 | $105.9K |
| Feb 4, 2022 | Troyen A Brennan | EVP and Chief Medical Officer | Sale | 47.9K | $110.00 | $5.3M |
Showing the 25 most recent of 82 Form 4 filings for CVS HEALTH Corp.
Most active CVS insiders
- Troyen A Brennan9 filings
- Edward J Ludwig7 filings
- James David Clark7 filings
- Thomas M Moriarty7 filings
- Alan Lotvin6 filings
Ask anything about CVS insider activity
Use Trabud's AI agent to query CVS HEALTH Corp's Form 4 history in plain English — "Show me CVS CEO purchases this year" or compare it against any other ticker.
Open the AI agentCVS insider trading FAQ
Are CVS HEALTH Corp insiders buying or selling?
Across 82 SEC Form 4 filings, CVS HEALTH Corp (CVS) insiders reported 20 open-market purchases totaling $8.5M and 62 sales totaling $820.7M. That is a net selling position of $812.3M.
How many insiders trade CVS stock?
26 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for CVS HEALTH Corp. The most recent filing was accepted on May 21, 2026.
Where does Trabud get CVS insider trading data?
All CVS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.